AINDEX
Markets

LeMaitre Vascular, Inc. (LMAT)

LMATNASDAQ-GMMedical/Dental Instruments

$78.83

-2.34 (-2.88%) today

Regular session, Nov 10, 2:15 PM ET

-2.88% 1D
Market cap
$1.80bn
P/E
28.7
EPS, last 4 quarters
$2.75
Dividend yield
1.23%
Day range
$78.58 to $80.73
52-week range
$78.22 to $118.01
Average volume
278.2k
Previous close
$81.16

Analysts

6 covering

Hold3 buy, 3 hold, 0 sell

Targets a year out average $94.60, +20.0% from here

$81.00now $78.83$110.00

Earnings

next estimate $0.7500

Next report

Dec 2025

+1.5%

Mar 2026

+3.0%

Jun 2026

-8.6%

Sep 2026

-5.8%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$64.45m$66.55m$70.38m$67.97m
Gross profit$46.19m$48.40m$50.76m$48.70m
Operating income$18.83m$17.77m$20.40m$17.70m
Net income$15.58m$15.68m$17.05m$15.02m

Last four quarters: revenue $269.36m, margin 23.5%, free cash flow $67.00m

News

8 latest

The company

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon.

Sector
Health Care
Industry
Medical/Dental Instruments
Exchange
NASDAQ-GM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.